Sesamin attenuates neurotoxicity in mouse model of ischemic brain stroke

Saif Ahmad, Nehal M. Elsherbiny, Rizwanul Haque, M. Badruzzaman Khan, Tauheed Ishrat, Zahoor A. Shah, Mohammad M. Khan, Mehboob Ali, Arshad Jamal, Deepshikha Pande Katare, Gregory I. Liou, Kanchan Bhatia

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Stroke is a severe neurological disorder characterized by the abrupt loss of blood circulation into the brain resulting into wide ranging brain and behavior abnormalities. The present study was designed to evaluate molecular mechanism by which sesamin (SES) induces neuroprotection in mouse model of ischemic stroke. The results of this study demonstrate that SES treatment (30. mg/kg. bwt) significantly reduced infarction volume, lipid per-oxidation, cleaved-caspase-3 activation, and increased GSH activity following MCAO in adult male mouse. SES treatment also diminished iNOS and COX-2 protein expression, and significantly restored SOD activity and protein expression level in the ischemic cortex of the MCAO animals. Furthermore, SES treatment also significantly reduced inflammatory and oxidative stress markers including Iba1, Nox-2, Cox-2, peroxynitrite compared to placebo MCAO animals. Superoxide radical production, as studied by DHE staining method, was also significantly reduced in the ischemic cortex of SES treated compared to placebo MCAO animals. Likewise, downstream effects of superoxide free radicals i.e. MAPK/ERK and P38 activation was also significantly attenuated in SES treated compared to placebo MCAO animals. In conclusion, these results suggest that SES induces significant neuroprotection, by ameliorating many signaling pathways activated/deactivated following cerebral ischemia in adult mouse.

Original languageEnglish (US)
Pages (from-to)100-110
Number of pages11
JournalNeuroToxicology
Volume45
DOIs
StatePublished - Dec 1 2014
Externally publishedYes

Fingerprint

Brain
Stroke
Animals
Placebos
Superoxides
Chemical activation
Peroxynitrous Acid
Oxidative stress
Blood Circulation
Hemodynamics
p38 Mitogen-Activated Protein Kinases
sesamin
Nervous System Diseases
Brain Ischemia
Caspase 3
Infarction
Free Radicals
Proteins
Oxidative Stress
Therapeutics

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Toxicology

Cite this

Ahmad, S., Elsherbiny, N. M., Haque, R., Khan, M. B., Ishrat, T., Shah, Z. A., ... Bhatia, K. (2014). Sesamin attenuates neurotoxicity in mouse model of ischemic brain stroke. NeuroToxicology, 45, 100-110. https://doi.org/10.1016/j.neuro.2014.10.002

Sesamin attenuates neurotoxicity in mouse model of ischemic brain stroke. / Ahmad, Saif; Elsherbiny, Nehal M.; Haque, Rizwanul; Khan, M. Badruzzaman; Ishrat, Tauheed; Shah, Zahoor A.; Khan, Mohammad M.; Ali, Mehboob; Jamal, Arshad; Katare, Deepshikha Pande; Liou, Gregory I.; Bhatia, Kanchan.

In: NeuroToxicology, Vol. 45, 01.12.2014, p. 100-110.

Research output: Contribution to journalArticle

Ahmad, S, Elsherbiny, NM, Haque, R, Khan, MB, Ishrat, T, Shah, ZA, Khan, MM, Ali, M, Jamal, A, Katare, DP, Liou, GI & Bhatia, K 2014, 'Sesamin attenuates neurotoxicity in mouse model of ischemic brain stroke', NeuroToxicology, vol. 45, pp. 100-110. https://doi.org/10.1016/j.neuro.2014.10.002
Ahmad, Saif ; Elsherbiny, Nehal M. ; Haque, Rizwanul ; Khan, M. Badruzzaman ; Ishrat, Tauheed ; Shah, Zahoor A. ; Khan, Mohammad M. ; Ali, Mehboob ; Jamal, Arshad ; Katare, Deepshikha Pande ; Liou, Gregory I. ; Bhatia, Kanchan. / Sesamin attenuates neurotoxicity in mouse model of ischemic brain stroke. In: NeuroToxicology. 2014 ; Vol. 45. pp. 100-110.
@article{ae60706919d14852927cab7987064eb0,
title = "Sesamin attenuates neurotoxicity in mouse model of ischemic brain stroke",
abstract = "Stroke is a severe neurological disorder characterized by the abrupt loss of blood circulation into the brain resulting into wide ranging brain and behavior abnormalities. The present study was designed to evaluate molecular mechanism by which sesamin (SES) induces neuroprotection in mouse model of ischemic stroke. The results of this study demonstrate that SES treatment (30. mg/kg. bwt) significantly reduced infarction volume, lipid per-oxidation, cleaved-caspase-3 activation, and increased GSH activity following MCAO in adult male mouse. SES treatment also diminished iNOS and COX-2 protein expression, and significantly restored SOD activity and protein expression level in the ischemic cortex of the MCAO animals. Furthermore, SES treatment also significantly reduced inflammatory and oxidative stress markers including Iba1, Nox-2, Cox-2, peroxynitrite compared to placebo MCAO animals. Superoxide radical production, as studied by DHE staining method, was also significantly reduced in the ischemic cortex of SES treated compared to placebo MCAO animals. Likewise, downstream effects of superoxide free radicals i.e. MAPK/ERK and P38 activation was also significantly attenuated in SES treated compared to placebo MCAO animals. In conclusion, these results suggest that SES induces significant neuroprotection, by ameliorating many signaling pathways activated/deactivated following cerebral ischemia in adult mouse.",
author = "Saif Ahmad and Elsherbiny, {Nehal M.} and Rizwanul Haque and Khan, {M. Badruzzaman} and Tauheed Ishrat and Shah, {Zahoor A.} and Khan, {Mohammad M.} and Mehboob Ali and Arshad Jamal and Katare, {Deepshikha Pande} and Liou, {Gregory I.} and Kanchan Bhatia",
year = "2014",
month = "12",
day = "1",
doi = "10.1016/j.neuro.2014.10.002",
language = "English (US)",
volume = "45",
pages = "100--110",
journal = "NeuroToxicology",
issn = "0161-813X",
publisher = "Elsevier",

}

TY - JOUR

T1 - Sesamin attenuates neurotoxicity in mouse model of ischemic brain stroke

AU - Ahmad, Saif

AU - Elsherbiny, Nehal M.

AU - Haque, Rizwanul

AU - Khan, M. Badruzzaman

AU - Ishrat, Tauheed

AU - Shah, Zahoor A.

AU - Khan, Mohammad M.

AU - Ali, Mehboob

AU - Jamal, Arshad

AU - Katare, Deepshikha Pande

AU - Liou, Gregory I.

AU - Bhatia, Kanchan

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Stroke is a severe neurological disorder characterized by the abrupt loss of blood circulation into the brain resulting into wide ranging brain and behavior abnormalities. The present study was designed to evaluate molecular mechanism by which sesamin (SES) induces neuroprotection in mouse model of ischemic stroke. The results of this study demonstrate that SES treatment (30. mg/kg. bwt) significantly reduced infarction volume, lipid per-oxidation, cleaved-caspase-3 activation, and increased GSH activity following MCAO in adult male mouse. SES treatment also diminished iNOS and COX-2 protein expression, and significantly restored SOD activity and protein expression level in the ischemic cortex of the MCAO animals. Furthermore, SES treatment also significantly reduced inflammatory and oxidative stress markers including Iba1, Nox-2, Cox-2, peroxynitrite compared to placebo MCAO animals. Superoxide radical production, as studied by DHE staining method, was also significantly reduced in the ischemic cortex of SES treated compared to placebo MCAO animals. Likewise, downstream effects of superoxide free radicals i.e. MAPK/ERK and P38 activation was also significantly attenuated in SES treated compared to placebo MCAO animals. In conclusion, these results suggest that SES induces significant neuroprotection, by ameliorating many signaling pathways activated/deactivated following cerebral ischemia in adult mouse.

AB - Stroke is a severe neurological disorder characterized by the abrupt loss of blood circulation into the brain resulting into wide ranging brain and behavior abnormalities. The present study was designed to evaluate molecular mechanism by which sesamin (SES) induces neuroprotection in mouse model of ischemic stroke. The results of this study demonstrate that SES treatment (30. mg/kg. bwt) significantly reduced infarction volume, lipid per-oxidation, cleaved-caspase-3 activation, and increased GSH activity following MCAO in adult male mouse. SES treatment also diminished iNOS and COX-2 protein expression, and significantly restored SOD activity and protein expression level in the ischemic cortex of the MCAO animals. Furthermore, SES treatment also significantly reduced inflammatory and oxidative stress markers including Iba1, Nox-2, Cox-2, peroxynitrite compared to placebo MCAO animals. Superoxide radical production, as studied by DHE staining method, was also significantly reduced in the ischemic cortex of SES treated compared to placebo MCAO animals. Likewise, downstream effects of superoxide free radicals i.e. MAPK/ERK and P38 activation was also significantly attenuated in SES treated compared to placebo MCAO animals. In conclusion, these results suggest that SES induces significant neuroprotection, by ameliorating many signaling pathways activated/deactivated following cerebral ischemia in adult mouse.

UR - http://www.scopus.com/inward/record.url?scp=84908342100&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908342100&partnerID=8YFLogxK

U2 - 10.1016/j.neuro.2014.10.002

DO - 10.1016/j.neuro.2014.10.002

M3 - Article

VL - 45

SP - 100

EP - 110

JO - NeuroToxicology

JF - NeuroToxicology

SN - 0161-813X

ER -